End-to-End Biosensor Solutions
End-to-End Biosensor Solutions with Advanced Enzyme Technology
At DirectSens, a full end-to-end solution for biosensor manufacturing is applied, where the entire process—from enzyme discovery to large-scale production—remains in-house. Advanced fermentation technology and bioinformatics are applied to optimize enzymes for modern sensor architectures. Enzyme production is scaled through precision fermentation to ensure consistent quality and performance in a variety of applications. ISO-certified facilities ensure that all products adhere to strict quality management standards. Quality control is implemented at every stage, from enzyme production through to final sensor shippment. This approach guarantees reliable product performance across all biosensor applications.
The discovery and optimization of enzymes are core activities at DirectSens, where advanced biotechnology methods are applied to enhance the function of naturally occurring enzymes. Bioinformatics tools are used to optimize enzyme design. By analyzing enzyme structures and functionalities, specific adjustments are made to improve performance. This method enables enzymes to be tailored for different biosensor applications, such as improving specificity or enhancing reaction speed. Through precision fermentation, large quantities of high-quality enzymes are produced. This process ensures that every batch meets consistent quality standards, supporting diverse applications across healthcare, environmental monitoring, and food safety.
A highly skilled team drives innovation at DirectSens, and strong ties to the University of Natural Resources and Life Sciences (BOKU) in Vienna ensure access to the latest academic research. This collaboration allows for cutting-edge developments in enzyme technology and biosensor systems, positioning DirectSens at the forefront of industry advancements.
Related Insights
Explore more from our latest news, technology updates, and industrial resources.

DirectSens® Presents State-of-the-Art Analytical Biotechnology Solutions at Analytica 2026

DirectSens’ Market-Leading LactoSens® BioSensor Technology acquired by Kerry Group P.L.C.

Improved process control through sugar analysis of oat drinks

A Breakthrough for Women’s Health: DirectSens Launches XpressGT to Combat Gestational Diabetes and More
